{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:11:31Z","timestamp":1790269891449,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:00:00Z","timestamp":1402531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:00:00Z","timestamp":1402531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2014.253","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T16:36:31Z","timestamp":1402590991000},"page":"e1289-e1289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"5","author":[{"given":"M J","family":"Barallobre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Perier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Delabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Arbon\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,12]]},"reference":[{"key":"BFcddis2014253_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2012.01.007","volume":"46","author":"F Guedj","year":"2012","unstructured":"Guedj F, Pereira PL, Najas S, Barallobre MJ, Chabert C, Souchet B et al. DYRK1A: a master regulatory protein controlling brain growth. Neurobiol Dis 2012; 46: 190\u2013203.","journal-title":"Neurobiol Dis"},{"key":"BFcddis2014253_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ajhg.2008.03.001","volume":"82","author":"RS Moller","year":"2008","unstructured":"Moller RS, Kubart S, Hoeltzenbein M, Heye B, Vogel I, Hansen CP et al. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am J Hum Genet 2008; 82: 1165\u20131170.","journal-title":"Am J Hum Genet"},{"key":"BFcddis2014253_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1399-0004.2010.01544.x","volume":"79","author":"BW van Bon","year":"2011","unstructured":"van Bon BW, Hoischen A, Hehir-Kwa J, de Brouwer AP, Ruivenkamp C, Gijsbers AC et al. Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly. Clin Genet 2011; 79: 296\u2013299.","journal-title":"Clin Genet"},{"key":"BFcddis2014253_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/ajmg.a.33735","volume":"155A","author":"T Yamamoto","year":"2011","unstructured":"Yamamoto T, Shimojima K, Nishizawa T, Matsuo M, Ito M, Imai K . Clinical manifestations of the deletion of Down syndrome critical region including DYRK1A and KCNJ6. Am J Med Genet A 2011; 155A: 113\u2013119.","journal-title":"Am J Med Genet A"},{"key":"BFcddis2014253_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/jmedgenet-2012-101251","volume":"49","author":"JB Courcet","year":"2012","unstructured":"Courcet JB, Faivre L, Malzac P, Masurel-Paulet A, Lopez E, Callier P et al. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy. J Med Genet 2012; 49: 731\u2013736.","journal-title":"J Med Genet"},{"key":"BFcddis2014253_CR6","doi-asserted-by":"publisher","first-page":"6636","DOI":"10.1128\/MCB.22.18.6636-6647.2002","volume":"22","author":"V Fotaki","year":"2002","unstructured":"Fotaki V, Dierssen M, Alcantara S, Martinez S, Marti E, Casas C et al. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol Cell Biol 2002; 22: 6636\u20136647.","journal-title":"Mol Cell Biol"},{"key":"BFcddis2014253_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0896-6273(95)90286-4","volume":"14","author":"F Tejedor","year":"1995","unstructured":"Tejedor F, Zhu XR, Kaltenbach E, Ackermann A, Baumann A, Canal I et al. minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron 1995; 14: 287\u2013301.","journal-title":"Neuron"},{"key":"BFcddis2014253_CR8","first-page":"62","volume":"57","author":"Z Chettouh","year":"1995","unstructured":"Chettouh Z, Croquette MF, Delobel B, Gilgenkrants S, Leonard C, Maunoury C et al. Molecular mapping of 21 features associated with partial monosomy 21: involvement of the APP-SOD1 region. Am J Hum Genet 1995; 57: 62\u201371.","journal-title":"Am J Hum Genet"},{"key":"BFcddis2014253_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1742-4658.2010.07956.x","volume":"278","author":"W Becker","year":"2011","unstructured":"Becker W, Sippl W . Activation, regulation, and inhibition of DYRK1A. FEBS J 2011; 278: 246\u2013256.","journal-title":"FEBS J"},{"key":"BFcddis2014253_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1742-4658.2010.07955.x","volume":"278","author":"J Wegiel","year":"2011","unstructured":"Wegiel J, Gong CX, Hwang YW . The role of DYRK1A in neurodegenerative diseases. FEBS J 2011; 278: 236\u2013245.","journal-title":"FEBS J"},{"key":"BFcddis2014253_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","volume":"35","author":"TF Haydar","year":"2012","unstructured":"Haydar TF, Reeves RH . Trisomy 21 and early brain development. Trends Neurosci 2012; 35: 81\u201391.","journal-title":"Trends Neurosci"},{"key":"BFcddis2014253_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1742-4658.2010.07954.x","volume":"278","author":"FJ Tejedor","year":"2011","unstructured":"Tejedor FJ, Hammerle B . MNB\/DYRK1A as a multiple regulator of neuronal development. FEBS J 2011; 278: 223\u2013235.","journal-title":"FEBS J"},{"key":"BFcddis2014253_CR13","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4711-09.2010","volume":"30","author":"O Yabut","year":"2010","unstructured":"Yabut O, Domogauer J, D'Arcangelo G . Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells. J Neurosci 2010; 30: 4004\u20134014.","journal-title":"J Neurosci"},{"key":"BFcddis2014253_CR14","doi-asserted-by":"publisher","first-page":"31895","DOI":"10.1074\/jbc.M110.147520","volume":"285","author":"J Park","year":"2010","unstructured":"Park J, Oh Y, Yoo L, Jung MS, Song WJ, Lee SH et al. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells. J Biol Chem 2010; 285: 31895\u201331906.","journal-title":"J Biol Chem"},{"key":"BFcddis2014253_CR15","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1242\/dev.066167","volume":"138","author":"B Hammerle","year":"2011","unstructured":"Hammerle B, Ulin E, Guimera J, Becker W, Guillemot F, Tejedor FJ . Transient expression of Mnb\/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling. Development 2011; 138: 2543\u20132554.","journal-title":"Development"},{"key":"BFcddis2014253_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.devcel.2008.10.014","volume":"15","author":"A Laguna","year":"2008","unstructured":"Laguna A, Aranda S, Barallobre MJ, Barhoum R, Fernandez E, Fotaki V et al. The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. Dev Cell 2008; 15: 841\u2013853.","journal-title":"Dev Cell"},{"key":"BFcddis2014253_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuron.2012.09.023","volume":"76","author":"NX Tritsch","year":"2012","unstructured":"Tritsch NX, Sabatini BL . Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 2012; 76: 33\u201350.","journal-title":"Neuron"},{"key":"BFcddis2014253_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1601-183X.2006.00285.x","volume":"6","author":"M Martinez de Lagran","year":"2007","unstructured":"Martinez de Lagran M, Bortolozzi A, Millan O, Gispert JD, Gonzalez JR, Arbones ML et al. Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+\/\u2212). Genes Brain Behav 2007; 6: 569\u2013578.","journal-title":"Genes Brain Behav"},{"key":"BFcddis2014253_CR19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1037\/0735-7044.118.4.815","volume":"118","author":"V Fotaki","year":"2004","unstructured":"Fotaki V, Martinez De Lagran M, Estivill X, Arbones M, Dierssen M . Haploinsufficiency of Dyrk1A in mice leads to specific alterations in the development and regulation of motor activity. Behav Neurosci 2004; 118: 815\u2013821.","journal-title":"Behav Neurosci"},{"key":"BFcddis2014253_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrm2153","volume":"8","author":"SJ Riedl","year":"2007","unstructured":"Riedl SJ, Salvesen GS . The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007; 8: 405\u2013413.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcddis2014253_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrn1100","volume":"4","author":"M Vila","year":"2003","unstructured":"Vila M, Przedborski S . Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci 2003; 4: 365\u2013375.","journal-title":"Nat Rev Neurosci"},{"key":"BFcddis2014253_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/dvdy.20467","volume":"234","author":"F Marin","year":"2005","unstructured":"Marin F, Herrero MT, Vyas S, Puelles L . Ontogeny of tyrosine hydroxylase mRNA expression in mid- and forebrain: neuromeric pattern and novel positive regions. Dev Dyn 2005; 234: 709\u2013717.","journal-title":"Dev Dyn"},{"key":"BFcddis2014253_CR23","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1242\/dev.02501","volume":"133","author":"SL Ang","year":"2006","unstructured":"Ang SL . Transcriptional control of midbrain dopaminergic neuron development. Development 2006; 133: 3499\u20133506.","journal-title":"Development"},{"key":"BFcddis2014253_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.stem.2010.06.021","volume":"7","author":"SR Ferron","year":"2010","unstructured":"Ferron SR, Pozo N, Laguna A, Aranda S, Porlan E, Moreno M et al. Regulated segregation of kinase Dyrk1A during asymmetric neural stem cell division is critical for EGFR-mediated biased signaling. Cell Stem Cell 2010; 7: 367\u2013379.","journal-title":"Cell Stem Cell"},{"key":"BFcddis2014253_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1749-6632.2003.tb07464.x","volume":"991","author":"RE Burke","year":"2003","unstructured":"Burke RE . Postnatal developmental programmed cell death in dopamine neurons. Ann N Y Acad Sci 2003; 991: 69\u201379.","journal-title":"Ann N Y Acad Sci"},{"key":"BFcddis2014253_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/0306-4522(88)90041-3","volume":"25","author":"P Voorn","year":"1988","unstructured":"Voorn P, Kalsbeek A, Jorritsma-Byham B, Groenewegen HJ . The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 1988; 25: 857\u2013887.","journal-title":"Neuroscience"},{"key":"BFcddis2014253_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/1096-9861(20000828)424:3<476::AID-CNE6>3.0.CO;2-0","volume":"424","author":"V Jackson-Lewis","year":"2000","unstructured":"Jackson-Lewis V, Vila M, Djaldetti R, Guegan C, Liberatore G, Liu J et al. Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol 2000; 424: 476\u2013488.","journal-title":"J Comp Neurol"},{"key":"BFcddis2014253_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0014-4886(73)90008-3","volume":"38","author":"T Hattori","year":"1973","unstructured":"Hattori T, McGeer PL . Synaptogenesis in the corpus striatum of infant rat. Exp Neurol 1973; 38: 70\u201379.","journal-title":"Exp Neurol"},{"key":"BFcddis2014253_CR29","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033","volume":"147","author":"Y Fuchs","year":"2011","unstructured":"Fuchs Y, Steller H . Programmed cell death in animal development and disease. Cell 2011; 147: 742\u2013758.","journal-title":"Cell"},{"key":"BFcddis2014253_CR30","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1111\/j.1742-4658.2009.07330.x","volume":"276","author":"LA Allan","year":"2009","unstructured":"Allan LA, Clarke PR . Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. FEBS J 2009; 276: 6063\u20136073.","journal-title":"FEBS J"},{"key":"BFcddis2014253_CR31","doi-asserted-by":"publisher","first-page":"6268","DOI":"10.1111\/j.1742-4658.2008.06751.x","volume":"275","author":"A Seifert","year":"2008","unstructured":"Seifert A, Allan LA, Clarke PR . DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine. FEBS J 2008; 275: 6268\u20136280.","journal-title":"FEBS J"},{"key":"BFcddis2014253_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/ars.2011.4074","volume":"16","author":"C Perier","year":"2012","unstructured":"Perier C, Bove J, Vila M . Mitochondria and programmed cell death in Parkinson\u2019s disease: apoptosis and beyond. Antioxid Redox Signal 2012; 16: 883\u2013895.","journal-title":"Antioxid Redox Signal"},{"key":"BFcddis2014253_CR33","first-page":"310","volume":"309","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard PA Jr . Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 1983; 309: 310.","journal-title":"N Engl J Med"},{"key":"BFcddis2014253_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1096\/fj.10-165837","volume":"25","author":"S Aranda","year":"2011","unstructured":"Aranda S, Laguna A, de la Luna S . DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. FASEB J 2011; 25: 449\u2013462.","journal-title":"FASEB J"},{"key":"BFcddis2014253_CR35","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1073\/pnas.051633998","volume":"98","author":"M Vila","year":"2001","unstructured":"Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D et al. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 2001; 98: 2837\u20132842.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014253_CR36","doi-asserted-by":"publisher","first-page":"19126","DOI":"10.1073\/pnas.0508215102","volume":"102","author":"C Perier","year":"2005","unstructured":"Perier C, Tieu K, Guegan C, Caspersen C, Jackson-Lewis V, Carelli V et al. Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc Natl Acad Sci USA 2005; 102: 19126\u201319131.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014253_CR37","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1073\/pnas.0609874104","volume":"104","author":"C Perier","year":"2007","unstructured":"Perier C, Bove J, Wu DC, Dehay B, Choi DK, Jackson-Lewis V et al. Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson\u2019s disease. Proc Natl Acad Sci USA 2007; 104: 8161\u20138166.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014253_CR38","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.cellsig.2009.06.009","volume":"21","author":"A Seifert","year":"2009","unstructured":"Seifert A, Clarke PR . p38alpha- and DYRK1A-dependent phosphorylation of caspase-9 at an inhibitory site in response to hyperosmotic stress. Cell Signal 2009; 21: 1626\u20131633.","journal-title":"Cell Signal"},{"key":"BFcddis2014253_CR39","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.cell.2005.03.034","volume":"121","author":"PA Lochhead","year":"2005","unstructured":"Lochhead PA, Sibbet G, Morrice N, Cleghon V . Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 2005; 121: 925\u2013936.","journal-title":"Cell"},{"key":"BFcddis2014253_CR40","doi-asserted-by":"publisher","first-page":"7467","DOI":"10.1523\/JNEUROSCI.1877-08.2008","volume":"28","author":"LY Yu","year":"2008","unstructured":"Yu LY, Saarma M, Arumae U . Death receptors and caspases but not mitochondria are activated in the GDNF- or BDNF-deprived dopaminergic neurons. J Neurosci 2008; 28: 7467\u20137475.","journal-title":"J Neurosci"},{"key":"BFcddis2014253_CR41","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.nbd.2004.07.021","volume":"17","author":"L Yang","year":"2004","unstructured":"Yang L, Sugama S, Mischak RP, Kiaei M, Bizat N, Brouillet E et al. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo. Neurobiol Dis 2004; 17: 250\u2013259.","journal-title":"Neurobiol Dis"},{"key":"BFcddis2014253_CR42","doi-asserted-by":"publisher","first-page":"9519","DOI":"10.1523\/JNEUROSCI.21-24-09519.2001","volume":"21","author":"V Viswanath","year":"2001","unstructured":"Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF, Yantiri F et al. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J Neurosci 2001; 21: 9519\u20139528.","journal-title":"J Neurosci"},{"key":"BFcddis2014253_CR43","doi-asserted-by":"publisher","first-page":"9126","DOI":"10.1523\/JNEUROSCI.20-24-09126.2000","volume":"20","author":"O Eberhardt","year":"2000","unstructured":"Eberhardt O, Coelln RV, Kugler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E et al. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2000; 20: 9126\u20139134.","journal-title":"J Neurosci"},{"key":"BFcddis2014253_CR44","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35037747","volume":"407","author":"DW Nicholson","year":"2000","unstructured":"Nicholson DW . From bench to clinic with apoptosis-based therapeutic agents. Nature 2000; 407: 810\u2013816.","journal-title":"Nature"},{"key":"BFcddis2014253_CR45","doi-asserted-by":"publisher","first-page":"33250","DOI":"10.1074\/jbc.M606147200","volume":"281","author":"EJ Kim","year":"2006","unstructured":"Kim EJ, Sung JY, Lee HJ, Rhim H, Hasegawa M, Iwatsubo T et al. Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation. J Biol Chem 2006; 281: 33250\u201333257.","journal-title":"J Biol Chem"},{"key":"BFcddis2014253_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/jnnp.54.1.34","volume":"54","author":"P Vieregge","year":"1991","unstructured":"Vieregge P, Ziemens G, Freudenberg M, Piosinski A, Muysers A, Schulze B . Extrapyramidal features in advanced Down\u2019s syndrome: clinical evaluation and family history. J Neurol Neurosurg Psychiatry 1991; 54: 34\u201338.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFcddis2014253_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/jnnp.62.3.289","volume":"62","author":"A Hestnes","year":"1997","unstructured":"Hestnes A, Daniel SE, Lees AJ, Brun A . Down's syndrome and Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62: 289.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFcddis2014253_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S . Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc 2007; 2: 141\u2013151.","journal-title":"Nat Protoc"},{"key":"BFcddis2014253_CR49","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1523\/JNEUROSCI.23-12-05178.2003","volume":"23","author":"LM Farkas","year":"2003","unstructured":"Farkas LM, Dunker N, Roussa E, Unsicker K, Krieglstein K . Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. J Neurosci 2003; 23: 5178\u20135186.","journal-title":"J Neurosci"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2014253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014253","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:13:42Z","timestamp":1672960422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2014253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,12]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6]]}},"alternative-id":["BFcddis2014253"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2014.253","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,12]]},"assertion":[{"value":"10 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}